Patents by Inventor Evan Dreyer

Evan Dreyer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Calcium blockers to treat proliferative vitreoretinopathy
    Publication number: 20050192322
    Abstract: Glutamate causes migration and proliferation of retinal pigment epithelium and/or glial cells, and glutamate antagonists can prevent, treat or reduce retinal pigment epithelium and/or glial migration and the subsequent development of proliferative vitreoretinopathy. Avoidance or management of proliferative vitreoretinopathy can be achieved by administering to the patient a compound capable of reducing glutamate-induced retinal cell migration in a concentration effective to reduce such migration.
    Type: Application
    Filed: July 6, 2004
    Publication date: September 1, 2005
    Applicant: Allergan Sales, Inc.
    Inventor: Evan Dreyer
  • Calcium blockers to treat proliferative retinal diseases
    Publication number: 20050009884
    Abstract: Glutamate causes migration and proliferation of retinal pigment epithelium and/or glial cells, and glutamate antagonists can prevent, treat or reduce retinal pigment epithelium and/or glial migration and the subsequent development of proliferative vitreoretinopathy. Avoidance or management of proliferative vitreoretinopathy can be achieved by administering to the patient a compound capable of reducing glutamate-induced retinal cell migration in a concentration effective to reduce such migration.
    Type: Application
    Filed: December 12, 2003
    Publication date: January 13, 2005
    Inventors: Evan Dreyer, Scott Whitcup, William Hare, Cun Jian Dong